Dr. Pascal M. Jabbour, MD

Dr. Jabbour practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Jabbour's NPI, 1710196100, was assigned on May 22, 2007. Dr. Jabbour graduated from St Joseph's University Medical School in 1998. Dr. Jabbour holds Pennsylvania license MD430555.

Dr. Jabbour's primary practice is Thomas Jefferson University Hospital, at 111 South 11th Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-6000.

Dr. Jabbour's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Jabbour is also affiliated with Lankenau Medical Center. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Jabbour to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jabbour practices, 7 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Jabbour's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Jabbour is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Jabbour's licenses on file in 5 states: Pennsylvania, Delaware, New Jersey, Florida and Colorado.

Dmand AI lists craniotomy among the conditions Dr. Jabbour treats.

CMS data shows 686 Medicare services from Dr. Jabbour across 14 procedure codes in 2024, for 267 Medicare patients. Medicare paid $96,312 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 267 Medicare patients who saw Dr. Jabbour in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jabbour's median patient age at 64, with 60% women.

In 2024, Dr. Jabbour wrote 115 Medicare Part D claims for 39 patients. 58% of them were for generic drugs. CMS names the drug for 97 of them, across 3 drugs with 11 or more claims each, at $28,234 in total drug cost. In 2023, CMS named 82 claims across 2 drugs.

Dr. Jabbour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jabbour as offering telehealth.

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 599 papers to Dr. Jabbour, published from 2004 to 2025. 2024 was the busiest year, with 63. The most frequent topics are Intracranial Aneurysm, Endovascular Procedures and Embolization, Therapeutic. Dr. Jabbour has published most often in World Neurosurg. Dr. Jabbour's most frequent co-authors are Robert M. Starke, MD, Michael Reid Gooch, MD and Stavropoula Ioannis Tjoumakaris, MD.

Dmand AI links Dr. Jabbour to 8 clinical trials. 1 is still active or recruiting. Conditions studied include Intracranial Aneurysm, Intracranial Arterial Diseases and Subarachnoid Hemorrhage. Microvention-Terumo, Inc. sponsors the most, 2.

CMS Open Payments shows 109 general payments to Dr. Jabbour from 18 drug and device companies from 2016 to 2025. Acquisitions make up the largest share, 32% of the total. Medtronic, Inc. paid the most, $78,954. It also lists 1 research payment totaling $3,520 in 2019.

Dmand AI lists 2 awards for Dr. Jabbour, most recently CMS Stage 1 EHR in 2013.

Dr. Jabbour graduated from St Joseph's University Medical School in 1998. Dr. Jabbour is a member of AANS and CNS.

Dr. Jabbour is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 13. Check the plan with the practice before a visit.